The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance

► We modeled deaths averted in persons vaccinated in 73 GAVI-eligible countries. ► Projected use of nine antigens during 2011-2020 is expected to avert 10 million deaths. ► Routine and supplemental measles vaccination is expected to avert an additional 13 million deaths. ► Most deaths averted will be in Africa and Southeast Asia, regions with high mortality.